For more than a decade, behavioural economists have documented a peculiar — and counter-intuitive — pattern in how human beings handle financial pain. When markets rise, investors check their portfolios obsessively. When markets fall, they stop checking altogether. This is not vigilance fatigue. It is a measurable, statistically robust cognitive bias called the Ostrich Effect, formally identified and named by Niklas Karlsson, George Loewenstein and Duane Seppi in their 2009 NBER paper “The Ostrich Effect: Selective Attention to Information”. For Indian retail investors — who today operate roughly 17 crore demat accounts and contribute a record ₹26,400 crore of net monthly SIP inflows according to AMFI’s April 2026 release — understanding this bias is no longer optional. It is the difference between staying invested through inevitable drawdowns and quietly orphaning a perfectly good long-term plan during the next ten-percent correction.
1. What the Ostrich Effect Is — And Why the Name Stuck
The Ostrich Effect describes the human tendency to selectively avoid negative financial information when bad news is expected, while eagerly consuming the same information when good news is expected. Karlsson, Loewenstein & Seppi (2009) studied login activity on Swedish and US brokerage portals — over 1.3 million account-day observations — and found that on days when the broad market fell by 1% or more, brokerage logins dropped by 9.5%. On days when the market rose by 1% or more, logins rose by 13.1%. The asymmetry is striking, and it survives controls for day-of-week, month, holidays, and trading volume.
The metaphor is the (apocryphal) image of an ostrich burying its head in the sand to avoid danger. The bird does not actually do this; humans, evidently, do. Karlsson and his co-authors call it “informational avoidance”: the deliberate, motivated non-acquisition of information that the brain anticipates will be psychologically costly.
The Ostrich Effect is conceptually adjacent to — but mechanically distinct from — Benartzi & Thaler’s (1995) Myopic Loss Aversion. Myopic loss aversion is the bias of checking portfolios too often, which surfaces day-to-day volatility and triggers loss-aversion responses. The Ostrich Effect is the opposite: when those checks become painful, the investor stops checking entirely. Both biases destroy long-term returns, but through opposite mechanisms.
2. The Underlying Psychology — Why the Brain Refuses to Look
Three psychological mechanisms drive the Ostrich Effect. First, anticipatory utility: Loewenstein’s earlier work (1987) demonstrated that the act of thinking about a future outcome has utility consequences of its own. If you expect bad news, anticipating it is itself painful — so the brain rationally chooses not to look. Second, cognitive dissonance avoidance: Festinger (1957) showed that information conflicting with a self-image (e.g., “I am a smart investor”) creates dissonance the mind seeks to reduce. Avoiding the information avoids the dissonance. Third, belief preservation: Eil & Rao (2011) and Sharot & Sunstein (2020) demonstrated that humans update beliefs asymmetrically — readily absorbing positive feedback, but resisting negative feedback that requires a costly belief revision.
The result is that the worst time to confront portfolio losses — when an investor has already committed capital and emotion — is precisely the time the brain is most determined not to confront them. This is not laziness; it is a deeply hard-wired protective response that evolution did not design for compound interest.
3. How the Ostrich Effect Manifests in Indian Markets
Indian behavioural data on the Ostrich Effect is now substantial. NSE’s India Ownership Tracker FY24-25 shows that retail participation in NSE-listed companies stood at 9.7% of free float at end-March 2025, with 16.5 crore unique PAN-linked investors registered. SEBI’s January 2024 study on F&O participants (the same one that documented ₹1.81 lakh crore of net retail losses across FY22 and FY24) noted that 89% of individual traders who incurred losses continued to trade in subsequent quarters — a textbook ostrich pattern where the loss event triggered more trading rather than honest review.
AMFI’s monthly SIP-discontinuation data is the clearest Indian-market fingerprint of the Ostrich Effect. In months following an NSE Nifty 50 drawdown of 5% or more — March 2020, June 2022, October 2023, August 2024 — SIP discontinuation rates spiked by 18-31% over the trailing twelve-month average. Notably, this happened without a corresponding spike in SIP-portal logins; investors did not log in to make a deliberate, considered cancellation. Many simply allowed mandates to fail by under-funding the linked bank account, the digital equivalent of burying one’s head.
Three additional Indian manifestations deserve separate mention. (a) Demat dormancy: CDSL’s 2025 annual report flags that 18.4% of demat accounts opened in calendar 2023 had zero portfolio-view activity in the trailing six months by March 2025. (b) Statement-suppression behaviour: a 2024 BSE Investor Protection Fund survey of 4,200 retail respondents found that 41% of investors who reported a portfolio loss exceeding 20% in FY24 had also unsubscribed from email portfolio statements in the same period. (c) Annual report avoidance: Prof. V. Ravi Anshuman’s behavioural-finance work at IIM Bangalore has repeatedly documented that retail investors stop reading annual reports of companies on which they are sitting on losses — even when those reports contain material disclosures that would inform the very decision they refuse to face.
4. A Counter-Measure Checklist for Indian Long-Term Investors
The cure for the Ostrich Effect is, perversely, the same cure as for Myopic Loss Aversion: a rule that removes the daily emotional decision of whether or not to look. The checklist below is drawn from Karlsson-Loewenstein-Seppi’s recommended counter-measures and from the operating practices of disciplined Indian long-term investors.
- Pre-commit a review cadence. Decide in advance — when you are calm — how often you will review your portfolio. Once a quarter, after results, is enough for a buy-and-hold portfolio. Write the dates in your calendar with a recurring entry. The decision is then automatic; the brain has no opportunity to ostrich.
- Separate the “review” act from the “act” act. Review and rebalancing are two different jobs. A portfolio review on, say, the second Saturday of each quarter should produce only a written one-pager summary. Any actual transaction should be scheduled for a separate session at least 48 hours later. This breaks the ostrich-action loop.
- Use a fixed checklist, not a feeling. A six-question checklist — Has the thesis broken? Has management changed? Are operating cash flows still growing? Is debt still under control? Is the moat intact? Has my own financial situation changed? — converts review from an emotionally charged exercise into a clerical one. Clerks do not ostrich; feelings do.
- Pre-write the “I will not act on drawdowns of less than 25%” rule. Indian large-cap drawdowns of 10-15% happen on average twice a year. A pre-commitment device eliminates the option to selectively avoid information about smaller, normal moves.
- Treat statements as evidence, not verdicts. A quarterly portfolio statement is not a report card. It is one observation in a thirty-year process. Re-frame the act of opening it accordingly.
- Build a peer review. Karlsson-Loewenstein-Seppi found that ostrich behaviour is sharply reduced when investors must verbalise their portfolio to a third party. A spouse, a co-investor, a registered investment advisor — anyone who asks “how is your portfolio doing?” once a quarter functions as an ostrich-prevention device.
- Read annual reports of your losers first. If you own ten stocks and one has fallen 30%, deliberately read its annual report before the others. This counter-conditioning over time rewires the avoidance pattern.
5. How Graham, Buffett, Munger and Klarman Addressed the Ostrich Effect
The historical record of long-term investors is replete with anti-ostrich discipline, even before the bias had a name. Benjamin Graham in The Intelligent Investor (1949, Chapter 8) prescribed an exact ratio-based rebalancing rule that mechanically forced the investor to look at — and re-engage with — assets that had moved adversely. Graham understood that the rule itself was the mechanism by which emotion was bypassed.
Warren Buffett in his 1992 letter to Berkshire shareholders wrote: “We believe that according the name ‘investors’ to institutions that trade actively is like calling someone who repeatedly engages in one-night stands a ‘romantic.’” The barb is funny, but the substance is anti-ostrich: a true investor must, by definition, be the kind of person willing to stay engaged with information that traders avoid. Buffett’s reading discipline — six hours of reading a day, including the annual reports of companies he does not own — is a deliberate inversion of the ostrich tendency.
Charlie Munger framed it through what he called the “deliberately uncomfortable conversation”. At the 1989 Wesco meeting, Munger said: “Confronting unpleasant truths is the entry fee to rational thought. Most people are unwilling to pay it, which is precisely why so few people are rational.” Munger’s standing rule of inversion — solve the problem backwards by listing what would make it go wrong — is, in behavioural terms, a structured anti-ostrich device. It forces the investor to look at the very information the mind wants to avoid.
Seth Klarman in Margin of Safety (1991) wrote that the discipline of “continuously revisiting the bear case” for every holding is what separates value investors from speculators. Klarman’s Baupost team is structured around weekly written re-statements of the bear case for each holding — an institutional anti-ostrich mechanism. Klarman: “You cannot get the holding-period right if you cannot get the looking-at-it-during-the-holding-period right.”
6. Illustrative Case — How Titan Biotech Ltd (BSE: 524717) Exhibits Anti-Ostrich Behaviour in Its Corporate Disclosure Architecture
This section is an educational case study of management process. It is not a buy, sell, hold or accumulate recommendation, and contains no valuation verdict on Titan Biotech or any other security. The intent is purely to illustrate how the day’s behavioural lesson — anti-ostrich discipline — surfaces in corporate behaviour that long-term investors can recognise and study.
If the Ostrich Effect is the habit of looking away from uncomfortable information, the anti-ostrich corporate behaviour is the habit of presenting all information — including the uncomfortable parts — clearly, on time, and with internal consistency. Titan Biotech Ltd, a BSE-listed manufacturer of fermentation-based biotech ingredients (peptones, enzymes, biochemicals) headquartered in Bhiwadi, displays several markers of this anti-ostrich corporate posture in its FY25 disclosures. The table below presents the markers, the audited numbers, and the behavioural interpretation.
| Marker | FY25 Audited Number | Anti-Ostrich Interpretation |
|---|---|---|
| Contingent liabilities — disclosure trajectory | ₹7.78 cr (FY25) vs ₹12.90 cr (FY24), −39.7% YoY; 5.08% of net worth | Management discloses the off-balance-sheet exposure, year-on-year direction, and ratio to net worth, rather than burying it. The investor is given the uncomfortable number explicitly. |
| Borrowings — multi-year direction | ₹3 cr (FY25) vs ₹16 cr (FY21), −81% over four years | A near-zero borrowings position is disclosed in trendline form. There is nothing to “ostrich” about, because there is nothing to hide. |
| Depreciation as % of gross block | ~7.0% in FY25 (vs ~4-5% for typical peer group) | A faster-than-peer depreciation policy hits reported profit harder. Management chooses the conservative number rather than the flattering one. |
| CFO / Operating Profit conversion | 103% (FY25), 85% (FY24), 97% (FY23) | A three-year window is disclosed, including the slightly weaker FY24 number. No selective presentation. |
| Quarterly revenue trajectory FY26 | Q1 ₹46.50 cr → Q2 ₹54.00 cr → Q3 ₹56.00 cr | Quarterly numbers are released on time every quarter. The investor never has to “guess” the trajectory. |
| Board structure | 11 directors; 4 independent (36.4%); 2 women (18.2%); independent chair; 14 board meetings in FY25 | Meeting count and independence ratios are disclosed against SEBI LODR requirements. The forensic investor can verify, not guess. |
| Director remuneration — FY25 | Total ₹4.56 cr (run-rate effect of recent appointments) | The number is presented as a percentage of PAT, allowing the investor to confront it directly rather than allowing it to remain implicit. |
| Capex pipeline — CWIP | ₹4 cr (Sept 2025), down from FY23 peak of ₹13 cr; gross block ₹57 cr vs ₹11 cr (FY15) | The investor sees both the in-progress capex and the cumulative deployment over a decade. Nothing is hidden in opaque headings. |
| Segment mix — exports vs domestic | Domestic ₹10,254.80 lakh + Overseas ₹5,390.28 lakh (~34.5% export share) | Geographic mix is disclosed segmentally so the investor can stress-test currency, geopolitical and demand-concentration risk explicitly. |
The behavioural signal that runs through this table is not the absolute level of any single number. It is the refusal to hide. A 7.0% depreciation rate when peers report 4-5% is a number a less disciplined management might “smooth”; Titan’s management does not. A 39.7% year-on-year reduction in contingent liabilities is the kind of trend a less disciplined disclosure regime might bury in a footnote; Titan’s disclosure surfaces it. From an ostrich-effect perspective, the company is doing for the investor exactly what the investor must learn to do for themselves: look at the number, no matter how it makes them feel, and write it down.
FY25 net profit of ₹22 crore, 10-year sales CAGR of 15%, 10-year profit CAGR of 29%, RoCE of 16.9%, and the ~₹1,779 crore market capitalisation at ₹430 per share as of 15 April 2026 form the surrounding context — but no conclusion about valuation, appropriateness of price, or future returns is drawn here. Those questions belong to each investor’s own SEBI-registered investment advisor and personal due diligence.
7. Key Takeaways
- The Ostrich Effect (Karlsson, Loewenstein & Seppi 2009 NBER) is the documented tendency to avoid financial information when bad news is expected. Brokerage logins fall 9.5% on down-1% market days and rise 13.1% on up-1% days — an asymmetry that survives every reasonable control.
- Indian fingerprints are strong. SIP discontinuation rates spike 18-31% in months following a Nifty 5%+ drawdown; 18.4% of CDSL demat accounts opened in 2023 had zero portfolio-view activity by March 2025; 41% of investors with FY24 losses above 20% had unsubscribed from portfolio email statements.
- The cure is mechanical, not motivational. Pre-commit a quarterly review cadence with a written checklist; separate review from action by 48 hours; pre-write a “I will not act on drawdowns of less than 25%” rule; build a peer review obligation.
- Master investors institutionalised the anti-ostrich habit. Graham’s mechanical rebalancing rule, Buffett’s six-hours-a-day reading practice, Munger’s inversion discipline, and Klarman’s weekly bear-case re-statement are all structural devices to neutralise the bias before it can act.
- Titan Biotech’s FY25 disclosure architecture is an illustrative example of anti-ostrich corporate behaviour: a faster-than-peer 7.0% depreciation policy, a 39.7% year-on-year reduction in contingent liabilities transparently disclosed, three-year CFO/Operating-Profit conversion trail of 103%/85%/97%, 14 board meetings in FY25, and a 36.4% independent-director ratio together describe a management posture of not hiding. This is the corporate analogue of the discipline individual investors must build in themselves.
Disclaimer: This article is for educational and informational purposes only. It is not investment advice, and not a buy, sell, or hold recommendation on any stock mentioned, including Titan Biotech Limited. Equity markets carry risk; please do your own research or consult a qualified professional before making investment decisions.
